Advances in Clinical and Experimental Medicine

Adv Clin Exp Med
Impact Factor (IF) – 1.514
Index Copernicus (ICV 2018) – 157.72
MNiSW – 40
Average rejection rate – 84.38%
ISSN 1899–5276 (print)
ISSN 2451-2680 (online)
Periodicity – monthly

Download PDF

Advances in Clinical and Experimental Medicine

2014, vol. 23, nr 2, March-April, p. 205–213

Publication type: original article

Language: English

The Impact of Selected Preparations of Trace Elements – Magnesium, Potassium, Calcium, and Zinc on the Release of Diclofenac Sodium from Enteric Coated Tablets and from Sustained Release Capsules

Paweł Biernat1,A,B,C,D, Witold Musiał1,D, Dorota Gosławska1,B,C,D, Janusz Pluta1,E,F

1 Department of Pharmaceutical Technology, Wroclaw Medical University, Poland

Abstract

Background. In an aging society, many patients require long-term treatment. This fact is associated clearly with the simultaneous occurrence of lifestyle diseases such as hypertension, diabetes, and even osteoarthritis. Concomitant medications, which are a common practice, pose a major threat of an interaction between these drugs. Very popular now “fast way of life” that makes people have less and less time to prepare well-balanced meals of high nutritional value. The result of this lifestyle is an increased need for supplementation preparations necessary vitamins and minerals. Given the wide availability of dietary supplements (shops, kiosks, petrol stations) raises the question about the possibility of an interaction between the uncontrolled intake of dietary supplements and medications received in the most common diseases of civilization.
Objectives. The aim of this study was to investigate the effect of the most important minerals (magnesium, potassium, calcium, zinc) contained in the popular nutritional supplements, the release also often used as an anti-pain, anti-inflammatory, diclofenac sodium from the different formulations.
Results. Among the many as sodium diclofenac selected two most common: film-coated tablets and sustained release capsules. The study showed a significant effect of minerals on the release of diclofenac sodium and differences that impact, depending on the test form of the drug.

Key words

diclofenac, magnesium, potassium, calcium, zinc, release.

References (26)

  1. Charman N, CJ Porter H, Mith S, Dressman BJ: Physicochemical and Physiological Mechanisms for the effects of food on drug absorption: the role of Lipids and pH. J Pharm Sci 1997, 86, 269–282.
  2. Fleisher D, Li C, Zhou Y, Pao LH, Karim A: Drug, meal and Formulation interactions influencing drug absorption after oral administration. Clin Pharmacokinet 1999, 36, 233–254.
  3. Kostowski W, Herman ZS: Pharmacology. Grounds for pharmacovigilance. PZWL Medical Publisher Warsaw 2007.
  4. http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?id=7872
  5. Willis JV, Kendall MJ, Flinn RM, Thornhill DP, Welling PG: The Pharmacokinetics of Diclofenac Sodium Following intravenous administration and oral. Eur J Clin Pharmacol 1979, 16, 405–410.
  6. Bertocchi P, Antoniella E, Valvo L, Alimonti S, Memoli A: Diclofenac sodium tablets MultiSource Prolonged release-a comparative study on the Dissolution profiles. J Pharm Biomed Anal 2005, 37, 679–685.
  7. Piwowarczyk K: Pharmindex. Publisher MediMedia International Sp. z o.o., Warsaw 2012.
  8. Gertig H, Przysławski J: Bromatologia. PZWL Medical Publisher, Warsaw 2006.
  9. Laires MJ, Monteiro CP, Bicho M: Role of cellular magnesium in health and human disease. Front Biosci 2004, 9, 262–276.
  10. Lopez-Ridaura R, Willett WC, Rimm EB, Liu S, Stampfer MJ, Manson JE, Hu FB: Magnesium intake and risk of type 2 diabetes in men and women. Diabetes Care 2004, 27, 134–140.
  11. Musso CG: Magnesium metabolism in health and disease. Int Urol Nephrol 2009, 41, 357–362.
  12. Thwaites D, Anderson C: H+-coupled nutrient, micronutrient and drug transporters in the mammalian small intestine. Exp Physiol 2007, 92, 603–619.
  13. Charman N, Porter C: Physiochemical and physiological mechanism for the effects of food on drugs absorption: the role of lipids and pH. J Pharm Sci 1997, 86, 269–282.
  14. Fleisher D, Li C: Drug, meal and formulation interaction influencing drug absorption after oral administration. Clin Pharmacokinet 1999, 26, 233–254.
  15. Foster C, Mistry N, Peddi PF, Sharma S: The Washington manual of medical therapeutics. Wolters Kluwer Health 2012.
  16. Trzecziakiewicz A, Opolski A, Mazur A: TRPM7: a protein responsible for magnesium homeostasis in a cell, Post Hig Med Dosw (online) 2005, 59, 496–502.
  17. Welch Ross, Robin M, Graham D: Perspectives on Enhancing the Nutritional Quality of Food Crops with Trace Elements. Fertilizing Crops to Improve Human Health: a Scientific Review 2012, 65.
  18. http://www.doz.pl/czytelnia/a70-Potas_–_regulator_zdrowia
  19. Pemberton J: Oesophageal obstruction and ulceration Caused by oral potassium therapy. Br Heart J 1970, 32, 267–268.
  20. Yasuno T, Okamoto H, Nagai M, Kimura S, Yamamoto T, Nagano K, Yamamoto A: The disposition and intestinal absorption of zinc in rats. Eur J Pharm Sci 2011, 3, 410–415.
  21. http://books.google.com/books?hl=pl&lr=&id=xKjJpHqHUdAC&oi=fnd&pg=PA11&dq=Pharmacodynamics+of +micronutrients&ots=qrdawYx2Ai&sig=Sn0Aj4eSoJ9noSiZIfnnzvn97RE#PPP1,M1
  22. Puzanowska-Tarasiewicz H., Kuźmicka L., Tarasiewicz M.: Biological function of some elements and their compounds.III. Zinc – component and activator of enzymes. Pol Merk Lek 2009, 27, 419–422.
  23. Prasad S: Zinc: role in immunity, oxidative stress and chronic inflammation. Curr Opin Clin Nutr Metab Care 2009, 12, 646–652.
  24. Sabanayagam C, Shankar A: Serum calcium levels and hypertension among US adults. J Clin Hypertens 2011, 13, 716–721.
  25. Czerwonogrodzka A, Pyrżak B, Majcher A, Rumińska M, Rymkiewicz-Kluczyńska B, Jeznach-Steinhagen A: Assessment of dietary calcium intake on metabolic syndrome frequency in obese children and adolescents. Endokr Diabet Chor Przem Mat Wieku Rozwoj 2008, 14, 231–235.
  26. Houston MC: The role of cellular micronutrient analysis, nutraceuticals, vitamins, antioxidants and minerals in the prevention and treatment of hypertension and cardiovascular disease. Ther Adv Cardiovasc Dis 2010, 4, 165–183.